US 10947312
Human antibodies to GFRα3 and methods of making thereof
granted A61KA61K2039/505A61K39/001103
Quick answer
US patent 10947312 (Human antibodies to GFRα3 and methods of making thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K39/001103, A61K39/39533, A61K39/39541